![](https://www.signifyresearch.net/wp-content/uploads/2024/02/AdobeStock_299581576-564x420.jpg)
Written by
![Alan Stoddart headshot](https://www.signifyresearch.net/wp-content/uploads/2023/12/Alan-New-for-Website-150x150.jpg)
Alan Stoddart
HeartFlow has continued to build on its success, recently announcing that it is set to go public in a deal worth $2.8bn. This Premium Insight looks at how the vendor created this value, and what its next steps will be.
The insight is part of Signify Research’s Premium Insight – Medical Imaging subscription service.
To view the full insight on this development hit the Request Access button above for either a complimentary one month trial or to purchase a subscription.
The Signify Research’s Premium Insight – Medical Imaging subscription service provides:
- Approximately 100 actionable and up to the moment Premium Insights per year.
- A subscription to Signify Premium Insights – Medical Imaging provides compelling thought leadership on the most pertinent developments in healthcare technology.
- This service utilises Signify Research’s expansive market data to properly appraise and interpret breaking news stories.
- Major market moves and industry-changing announcements are evaluated as they unfold, and the considered opinions of Signify Research’s expert analysts are shared to provide insight into current developments.
- Key vendors, technologies and conferences are followed, with updates carefully scrutinised to ensure that the most important details are revealed and properly assessed.
Read the full insight with a Signify Premium Insights - Medical Imaging subscription